Table of Contents

Volume 105, Issue 11 (1625-1804)
Published 22 November 2011



A call for collaboration in surgical oncology Open

R W Glynn and K J Sweeney

Br J Cancer 105: 1625-1626; doi:10.1038/bjc.2011.446

What is the future for surgical oncology? Open

A M Thompson

Br J Cancer 105: 1627; doi:10.1038/bjc.2011.447



Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments Open

H Payne and M Mason

Br J Cancer 105: 1628-1634; advance online publication, October 18, 2011; doi:10.1038/bjc.2011.385


Clinical Studies

Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies Open

V Grünwald, C Seidel, M Fenner, A Ganser, J Busch and S Weikert

Br J Cancer 105: 1635-1639; advance online publication, October 27, 2011; doi:10.1038/bjc.2011.389

Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients Open

G Bousquet, J Alexandre, C Le Tourneau, F Goldwasser, S Faivre, H de Mont-Serrat, R Kaiser, J L Misset and E Raymond

Br J Cancer 105: 1640-1645; advance online publication, October 25, 2011; doi:10.1038/bjc.2011.440

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial Open

B Melichar, E Casado, J Bridgewater, J Bennouna, M Campone, P Vitek, J-P Delord, J Cerman Jr, R Salazar, J Dvorak, C Sguotti, P Urban, K Viraswami-Appanna, E Tan and J Tabernero

Br J Cancer 105: 1646-1653; advance online publication, October 25, 2011; doi:10.1038/bjc.2011.438

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer Open

F Thomas, A A Motsinger-Reif, J M Hoskins, A Dvorak, S Roy, A Alyasiri, R J Myerson, J W Fleshman, B R Tan and H L McLeod

Br J Cancer 105: 1654-1662; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.442

Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients Open

S Romano, S Fratini, E Ricevuto, V Procaccini, G Stifano, M Mancini, M Di Mauro, C Ficorella and M Penco

Br J Cancer 105: 1663-1668; advance online publication, November 8, 2011; doi:10.1038/bjc.2011.439

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases Open

G Farshid, T Sullivan, P Downey, P G Gill and S Pieterse

Br J Cancer 105: 1669-1675; advance online publication, November 3, 2011; doi:10.1038/bjc.2011.466

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients Open

K B Lundin, M Henningson, M Hietala, C Ingvar, C Rose and H Jernström

Br J Cancer 105: 1676-1683; advance online publication, October 27, 2011; doi:10.1038/bjc.2011.441

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network Open

A Smith, D Howell, R Patmore, A Jack and E Roman

Br J Cancer 105: 1684-1692; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.450


Translational Therapeutics

Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer Open

M Kanai, H Ishiguro, Y Mori, T Kitano, T Nishimura, S Matsumoto, K Yanagihara, T Chiba and M Toi

Br J Cancer 105: 1693-1696; advance online publication, October 27, 2011; doi:10.1038/bjc.2011.398

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1 Open

Y Bertrand, J-C Currie, J Poirier, M Demeule, A Abulrob, D Fatehi, D Stanimirovic, H Sartelet, J-P Castaigne and R Béliveau

Br J Cancer 105: 1697-1707; advance online publication, October 25, 2011; doi:10.1038/bjc.2011.427

Rapid in vivo testing of drug response in multiple myeloma made possible by xenograft to turkey embryos Open

Y Farnoushi, M Cipok, S Kay, H Jan, A Ohana, E Naparstek, R S Goldstein and V R Deutsch

Br J Cancer 105: 1708-1718; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.445


Molecular Diagnostics

MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer Open

M P Myklebust, O Bruland, Ø Fluge, A Skarstein, L Balteskard and O Dahl

Br J Cancer 105: 1719-1725; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.457

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome Open

F Journe, H Id Boufker, L Van Kempen, M-D Galibert, M Wiedig, F Salès, A Theunis, D Nonclercq, A Frau, G Laurent, A Awada and G Ghanem

Br J Cancer 105: 1726-1732; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.451

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer Open

R Morimura, S Komatsu, D Ichikawa, H Takeshita, M Tsujiura, H Nagata, H Konishi, A Shiozaki, H Ikoma, K Okamoto, T Ochiai, H Taniguchi and E Otsuji

Br J Cancer 105: 1733-1740; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.453

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 Open

N M A White, H W Z Khella, J Grigull, S Adzovic, Y M Youssef, R J Honey, R Stewart, K T Pace, G A Bjarnason, M A S Jewett, A J Evans, M Gabril and G M Yousef

Br J Cancer 105: 1741-1749; advance online publication, October 27, 2011; doi:10.1038/bjc.2011.401

Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1 Open

N Nishioka, T Matsuoka, M Yashiro, K Hirakawa, K Olden and J D Roberts

Br J Cancer 105: 1750-1758; advance online publication, October 20, 2011; doi:10.1038/bjc.2011.434

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells Open

D Bose, L J Zimmerman, M Pierobon, E Petricoin, F Tozzi, A Parikh, F Fan, N Dallas, L Xia, P Gaur, S Samuel, D C Liebler and L M Ellis

Br J Cancer 105: 1759-1767; advance online publication, November 1, 2011; doi:10.1038/bjc.2011.449



Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case–control study Open

Y Benavente, G Mbisa, N Labo, D Casabonne, N Becker, M Maynadie, L Foretova, P L Cocco, A Nieters, A Staines, P Bofetta, P Brennan, D Whitby and S de Sanjosé

Br J Cancer 105: 1768-1771; advance online publication, September 27, 2011; doi:10.1038/bjc.2011.392

Risk of renal cell carcinoma in relation to blood telomere length in a population-based case–control study Open

J N Hofmann, A Baccarelli, K Schwartz, F G Davis, J J Ruterbusch, M Hoxha, B J McCarthy, S A Savage, S Wacholder, N Rothman, B I Graubard, J S Colt, W-H Chow and M P Purdue

Br J Cancer 105: 1772-1775; advance online publication, October 27, 2011; doi:10.1038/bjc.2011.444

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark Open

E T Chang, T Frøslev, H T Sørensen and L Pedersen

Br J Cancer 105: 1776-1782; advance online publication, October 25, 2011; doi:10.1038/bjc.2011.443

Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time Open

M E Kroll, C A Stiller, M F G Murphy and L M Carpenter

Br J Cancer 105: 1783-1787; advance online publication, October 25, 2011; doi:10.1038/bjc.2011.415

Comparing cancer mortality and GDP health expenditure in England and Wales with other major developed countries from 1979 to 2006 Open

C Pritchard and T Hickish

Br J Cancer 105: 1788-1794; advance online publication, October 4, 2011; doi:10.1038/bjc.2011.393

Cancer incidence in the United Kingdom: projections to the year 2030 Open

M Mistry, D M Parkin, A S Ahmad and P Sasieni

Br J Cancer 105: 1795-1803; advance online publication, October 27, 2011; doi:10.1038/bjc.2011.430


Book Review

Clinical fundamentals for radiation oncologists Open

D M Gujral and C M Nutting

Br J Cancer 105: 1804; doi:10.1038/bjc.2011.454